Poster Abstracts • OFID 2018:5 (Suppl 1) • S109 vs. rural 16 (29%)(P = 0.1)). The commonest perceived barriers to successful AMS for all hospitals were lack of dedicated infectious diseases and microbiology services (64 (60%)), lack of dedicated pharmacy resources (62 (59%)), and a lack of education for clinicians in antibiotic use (53 (50%)).
Background. The development of the infant gut microbiota influences the maturation of the host immune system and has been implicated in both short-and long-term health outcomes. In a healthy infant, the initial stages of gut microbiota development are characterized by the progressive acquisition and proliferation of anaerobes. In the neonatal intensive care unit (NICU), infants are often exposed to antibiotics which disturb the normal development of the gut microbiota. In this retrospective cross-sectional study, we aimed to the evaluate the effects of three different antibiotic regimens on the gut microbiota of infants in the NICU, focusing on the effect on anaerobe colonization.
Methods. From November 1, 2014 to April 30, 2015, stool swabs were collected from NICU patients at The Hospital for Sick Children. Infants were included in the study if they received any dose or duration of the following antibiotics: ampicillin and tobramycin (AT), ampicillin and cefotaxime (AC), or ampicillin, tobramycin, and metronidazole (ATM). DNA was extracted from stool swabs and subject to Illumina sequencing of the V4 hypervariable region of the 16S rRNA gene. Infants were stratified by gestational age (term or preterm). The first samples taken within 1 week after antibiotic exposure were analyzed for diversity measures, taxonomic composition, and anaerobe relative abundance.
Results. A total of 64 NICU infants were included in the study, 46 (71.9%) received AT, 7 (10.9%) received AC, and 11 (17.2%) received ATM. Term infants received either AT (19/46; 41.3%) or AC (7/7; 100%), whereas preterm infants received either AT (27/46; 58.7%) or ATM (11/11; 100%). Shannon diversity was not statistically significant between term infants receiving AT and AC or preterm infants receiving AT and ATM. However, the relative abundance of anaerobes was significantly decreased after exposure to ATM in comparison to preterm infants receiving AT (P < 0.005) Conclusion. Within 1 week after ATM therapy, the relative abundance of gut anaerobes in preterm infants were significantly decreased in comparison to preterm infants receiving a course of AT. Therefore, limiting the use of ATM in preterm infants may protect the developing gut microbiota.
Disclosures. Methods. Documentation of indication at our institution was required beginning March 30, 2017. All patients ≤18 years old that received ≥1 dose of intravenous (IV) vancomycin (VAN) or IV/intramuscular ceftriaxone (CTX) during a 1 month preintervention period and three postintervention study periods (at 0, 3, and 6 months following implementation) were included. Patients were only included once per study period. Data included timing of antibiotic administration, indication for use, infection at body site requiring potential dose modification, dose modification, and agreement between order and progress note.
Results. Median age of patients was 4.2 years. Most common indications for VAN (total: 789) were sepsis syndrome (26%, N = 204), febrile neutropenia (12%, N = 95), and suspected catheter-related bloodstream infection (10%, N = 77) and for CTX (total: 1,071) were sepsis syndrome (12%, N = 127), perforated appendicitis (12%, N = 125), and urinary tract infection (10%, N = 107). Conclusion. Agreement between orders and progress notes was less than 50% during the postintervention period for both antibiotics. Median time to administration decreased for CTX, but not VAN. Antibiotic modifications were more common in the postintervention periods. Methods. Antibacterial use (AU) was reviewed using the DASON Antimicrobial Stewardship Assessment Portal, which includes filters for National Healthcare Safety Network (NHSN) unit types. We performed a retrospective review of AU in pediatric units from January 1 to December 31, 2017. AU was summarized by days of therapy (DOT) and percent of total DOT for specific unit types and agents. AU rates were reported by DOT/1,000 patient-days.
Results. A total of 41 pediatric units were included from the 28 hospital DASON cohort: 11 Neonatal Critical Care or Step Down Nurseries, eight Pediatric Medical/ Surgical Wards, and 22 Well Baby Units. There were no pediatric (non-neonatal) critical care or oncology units. A total of 21,731 antibiotic DOT were attributable to pediatric units, accounting for 1.6% of all AU in the cohort. These include 5,585 (26%) DOT in Neonatal Critical Care (level II/III) Units, 4,898 (23%) in Pediatric Medical/ Surgical Units, 3,910 (18%) in Well Baby Units, 3,307 (15%) in Neonatal Critical Care (level III) Units, 3,217 (15%) in Step Down Neonatal Nurseries (level II), and 814 (4%) in Pediatric Medical Wards. Ampicillin (7,229 DOT, 33%), gentamicin (6,320 DOT, 29%), ceftriaxone (1,750 DOT, 8%), and vancomycin (1,462, 7%) were the most common antibiotics administered.
AU rates were 219 DOT/1,000 patient-days in children when compared with 979 in adults. Unit-specific rates ranged from 65 (Well Baby Units) to 1,081 DOT/1,000 patient-days (Pediatric Medical/Surgical Units). Rates in level II and III nurseries ranged from 302 to 697 DOT/1,000 patient-days.
Conclusion. Pediatric patients accounted for a small proportion of AU in community hospitals. AU rates on pediatric medical/surgical units were comparable with adult units. Although rates were lower in neonatal units, these units accounted for 75% of pediatric AU. Antibiotic exposure in the neonatal period has been associated with short-and long-term outcomes, including necrotizing enterocolitis, obesity, and atopy. This population would benefit from a dedicated focus from community hospital ASPs.
Disclosures. All authors: No reported disclosures. Background. Prospective audit and feedback (PAF) is an effective method of antimicrobial stewardship. Given the time-intensive nature of PAF and low rates of intervention, understanding predictors of PAF recommendation and acceptance is imperative. Prior studies have not examined the impact of microbiologic data on the rate of PAF recommendation or recommendation acceptance. We evaluated whether antimicrobials prescribed for patients with positive microbiologic culture data were more or less likely to have a PAF recommendation and whether the presence of culture data impacted recommendation acceptance.
Effect of Microbiologic Data on Prospective Audit and Feedback Recommendations
Methods. All PAF audits on antibiotic and antifungal medications for patients admitted to Lucile Packard Children's Hospital Stanford between April 18, 2017 and April 17, 2018 were included. The PAF program included all pediatric units and injectable antimicrobials active for >48 hours. PAF documentation was completed in the electronic health record and included the presence or absence of positive microbiologic culture data. Our primary outcome was a comparison of PAF recommendation rate based on the presence or absence of positive culture data. We also evaluated whether there were differences in the recommendation acceptance rate and the type of recommendation based on the presence or absence of positive culture data.
Results. Of the 3,250 audits performed during the study period, 802 (25%) had positive cultures at the time of audit documentation. Of the 802 audits with positive cultures, 299 resulted in a recommendation compared with 824 of the 2,448 audits without positive cultures (37% vs. 34%, P = 0.07). PAF recommendations were more likely to be followed when positive culture data were present at the time of audit (80% vs. 73%, P = 0.03). The most common recommendation in the presence of positive culture data was to change the antimicrobial (27%) while the most common recommendation in the absence of positive culture data was to stop the antimicrobial (30%).
Conclusion. The presence of positive microbiologic culture data did not impact the PAF recommendation rate. However, recommendations were more likely to be followed when there was concurrent positive culture data. This highlights the importance of obtaining culture data to direct antimicrobial therapy.
Disclosures. 1 Pediatrics, Nara Medical University, Kashihara, Japan, 2 Nara Prefecture General Medical Center, Nara, Japan Thursday, October 4, 2018: 12:30 PM Background. Antimicrobial stewardship programs (ASP) have been implemented in many hospitals, including NICU departments. Although tertiary hospitals have successfully introduced ASPs by antimicrobial stewardship teams, lots of community hospitals without pediatric infectious disease specialists have difficulty implementing ASP. We present a successful implementation of simple and feasible NICU antimicrobial stewardship program in a Japanese community hospital.
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Methods. We developed a protocol of antimicrobial treatment in the NICU department of Nara Prefecture General Medical Center, Nara, Japan and have implemented it from September 2017. The protocol consists of antimicrobial treatment criteria (criteria for starting antimicrobials for neonates with suspected early-onset infection, criteria of prolonged antimicrobial treatment for more than 48 hours and duration of treatment),
